Angiotropic lymphoma: An immunophenotypically and clinically heterogeneous lymphoma

Modern Pathology

Volumn 14, Issue 11, 2001, Pages 1147-1156

  Yegappan, Subramanian ^a   Coupland, Robert ^b   Arber, Daniel A ^c   Wang, Nancy ^a   Miocinovic, Ranko ^a   Tubbs, Raymond R ^a   Hsi, Eric D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CROSS CANCER INSTITUTE   (Canada)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Angiotropic; Autopsy; Immunohistochemistry; Immunophenotype; Lymphoma

Indexed keywords

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER CLASSIFICATION; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD20; ANTIGENS, CD45; ANTIGENS, CD5; ANTIGENS, CD79; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; RECEPTORS, ANTIGEN, B-CELL; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; VASCULAR NEOPLASMS;

EID: 0035169605     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880450     Document Type: Article

References (62)

1. Zur Kenntnis der systemisierten endotheliomatose der cutanen Blutgefabe (Reticuloendotheliose?)
2. Diffuse malignant proliferation of vascular endothelium. A possible new clinical and pathological entity
3. Intravascular endothelioma (endothelioma in situ, systemic endotheliomatosis)
4. Proliferating angioendotheliomatosis
5. Histiocytic lymphoma and malignant angioendotheliomatosis: One disease or two?
6. Malignant lymphoma and malignant angioendotheliomatosis: One disease
7. Malignant angioendotheliomatosis. An angiotropic lymphoma?
8. Reassessment of malignant angioendotheliomatosis. Evidence in favor of its reclassification as intravascular lymphomatosis
9. Intravascular large B-cell lymphoma. A report of five cases initially diagnosed by bone marrow biopsy
10. Intravascular large cell lymphoma: Clinicopathological, immuno-histochemical and molecular genetic studies
11. Intravascular large B-cell lymphoma: The CD5 antigen is expressed by a subset of cases
12. Intravascular malignant lymphomatosis (angiotropic large-cell lymphoma). A case report with evidence for T-cell lineage with polymerase chain reaction analysis
13. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
14. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
15. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997
16. Intravascular lymphomatosis: Clinicopathologic features and differential diagnosis
17. Intravascular large cell lymphoma associated with hypoalbuminemia
18. Intravascular lymphomatosis: A clinicopathologic study of 10 cases and assessment of response to chemotherapy
19. Malignant proliferative angioendotheliomatosis or angiotropic lymphoma associated with a soft-tissue lymphoma
20. Further evidence that malignant angioendotheliomatosis is an angiotropic large-cell lymphoma
21. Angiotropic lymphoma: Report of a case with histiocytic features
22. Intravascular histiocytosis
23. Angiotropic large cell lymphoma (intravascular lymphomatosis) occurring after follicular small cleaved cell lymphoma
24. Angiotropic large-cell lymphoma in a patient with adrenal insufficiency
25. Angiotropic large cell lymphoma: Simultaneous peripheral nerve and skeletal muscle involvement
26. Angiotrophic large cell lymphoma mimicking multiple sclerosis associated transverse myelitis
27. Malignant angioendotheliomatosis: An angiotropic lymphoma
28. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization
29. Mucosa-associated lymphoid tissue-type lymphomas occurring in post-transplantation patients
30. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type
31. Intravascular lymphomatosis. A systemic disease with neurologic manifestations
32. Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors
33. Cellular characteristics of neoplastic angioendotheliosis. An immunohistological marker study of 6 cases
34. Malignant histiocytosis-like B-cell lymphoma, a distinct pathologic variant of intravascular lymphomatosis: A report of five cases and review of the literature
35. Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations
36. Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reports
37. Lack of CD 29 (betal integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis
38. Intravascular lymphomatosis (angioendotheliomatosis): Evidence for a T-cell origin in two cases
39. A case of intravascular malignant lymphomatosis (angiotropic large-cell lymphoma) presenting memory T cell phenotype and its expression of adhesion molecules
40. Congenital angiotropic lymphoma (intravascular lymphomatosis) of the T-cell type
41. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma
42. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia
43. Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: Correlation with 3q27 and 18q21 chromosomal abnormalities
44. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders
45. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas
46. BCL-6 gene product, a 92-to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts
47. bcl-6 protein is identified in high-grade but not low-grade mucosa-associated lymphoid tissue lymphomas of the stomach
48. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes
49. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas
50. De novo CD5-positive diffuse large B-cell lymphoma: Clinical characteristics and therapeutic outcome
51. Proposals for the immunological classification of acute leukemias
52. Aberrant antigen expression detected by multiparameter three color flow cytometry in intermediate and high grade B-cell lymphomas
53. Primary non-Hodgkin lymphomas of the CNS-proliferation, oncoproteins and Epstein-Barr-virus
54. Epstein-Barr virus-related intravascular lymphomatosis
55. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): Association with Epstein-Barr viral infection
56. Epstein-Barr virus-associated intravascular lymphomatosis within Kaposi's sarcoma in an AIDS patient
57. Intravascular lymphomatosis-an indolent or aggressive entity?
58. Primary hepatic lymphoma presenting as intravascular lymphomatosis
59. T-cell rich b-cell non-hodgkin's lymphoma: A progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease
60. Intravascular lymphomatosis. A report of ten patients with central nervous system involvement and a review of the disease process
61. Successful autologous bone marrow transplantation in intravascular lymphomatosis
62. Intravascular large cell lymphoma: A patient with asymptomatic purpuric patches and a chronic clinical course